4
Changes in Ownership
Whitehawk Therapeutics, Inc. Filed Acc 0001754154-26-000002
CHIEF FINANCIAL OFFICER sold 2,594 shares at $3.31 ($8,585)
- CHIEF FINANCIAL OFFICER acquired 6,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Giacobello Scott M. CHIEF FINANCIAL OFFICER | 2026-03-01 | Option exercise | +6,750 | 30,694 | D: show line 1 in the form | ||
| Giacobello Scott M. CHIEF FINANCIAL OFFICER | 2026-03-02 | Sale | −2,594 | $3.31 | $8,585 | 28,100 | D: show line 2 in the form |
| Open-market sales · 2,594 sh · avg $3.31 · $8,585 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Giacobello Scott M. CHIEF FINANCIAL OFFICER | 2026-03-01 | Option exercise · Restricted Stock Units | −6,750 | 13,500 | D: show line 3 in the form |
Loading xslF345X05/form4-03102026_110300.xml…